Lobular neoplasia at percutaneous breast biopsy: Variables associated with carcinoma at surgical excision

American Journal of Roentgenology

Volumn 190, Issue 3, 2008, Pages 637-641

  Brem, Rachel F ^a   Lechner, Mary C ^b   Jackman, Roger J ^c   Rapelyea, Jocelyn A ^a   Evans, W Phil ^d   Philpotts, Liane E ^e   Hargreaves, Jonathan ^a   Wasden, Shane ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b PARK NICOLLET CLINIC   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Breast imaging; Lobular neoplasia; Mammography

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CARCINOMA; BREAST HYPERPLASIA; BREAST TUMOR; CARCINOMA IN SITU; DEVICE; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLING;

AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPLASIA; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 39749105846     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.2768     Document Type: Article

References (36)

1. Jackman RJ, Nowels K, Rodriguez-Soto J, Marzoni FA, Finkelstein SI, Shepard MJ. Stereotactic, automated, large-core needle biopsy of non-palpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology 1999; 210:799-805
2. Liberman L. Percutaneous image-guided core breast biopsy. Radiol Clin North Am 2002; 40:483-500
3. Berg W. Image-guided breast biopsy and management of high-risk lesions. Radiol Clin North Am 2004; 42:935-946
4. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotactic core biopsy of breast lesions: an indication for surgical biopsy. AJR 1995; 164:1111-1113
5. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA Jr. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 1994; 193:91-95
6. Lin PH, Clyde C, Bates DM, Garcia JM, Matsumoto GH, Girvin GW. Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia. Am J Surg 1998; 175:380-382
7. Darling ML, Smith DN, Lester SC, Kaelin C, Selland DL. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR 2000; 175:1341-1346
8. Jackman RJ, Birdwell RL, Tkeda DM. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? Radiology 2002; 224:548-554
9. Brem RF, Behrndt VS, Sanow L, Gatewood OMB. Atypical ductal hyperplasia: histologic underestimation of carcinoma in tissue harvested from impalpable breast lesions using 11-gauge stereotactically guided directional vacuum-assisted biopsy. AJR 1999; 172:1405-1407
10. Page DL, Dupont WD, Rogers L, Rados MS. Atypical hyperplasia lesions of the female breast: a long-term follow-up study. Cancer 1985; 55:2698-2708
11. Chuba PJ, Hamre MR, Yap J, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 2005; 23:5534-5541
12. Liberman L, Sama M, Susnik B, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. AJR 1999; 173:291-299
13. Berg WA, Mrose HE, Ioffe OB. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 2001; 218:503-509
14. Arpino G, Allied DC, Mohsin SK, Weiss HL, Conrow D, Elledge RM. Lobular neoplasia on core-needle biopsy: clinical significance. Cancer 2004; 101:242-250
15. Liberman L. Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am 2000; 38:791-807
16. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001; 218:497-502
17. Lomoschitz FM, Helbich T, Rudas M, et al. Stereotactic 11-gauge vacuum-assisted breast biopsy: influence of number of specimens on diagnostic accuracy. Radiology 2004; 232:897-903
18. Liberman L, Drotman M, Morris EA, et al. Imaging-histologic discordance at percutaneous breast biopsy. Cancer 2000; 89:2538-2546
19. Cohen MA. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core needle biopsy: some reasons why. Radiology 2004; 231:617-621
20. Burak WE, Owens KE, Tighe MB, et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg 2000; 135:700-703
21. Philpotts LE, Shaheen NA, Jain KS, Carter D, Lee CH. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology 2000; 216:831-837
22. O'Driscoll D, Britton P, Bobrow L, Wishart R, Sinnatamby R, Warren R. Lobular carcinoma in situ on core biopsy: what is the clinical significance? Clin Radiol 2001; 56:216-220
23. Shin SJ, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002; 126:697-701
24. Irfan K, Brem R. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy. Breast J 2002; 8:230-233
25. Renshaw AA, Cartagena N, Derhagopian RP, Gould EW. Lobular neoplasia in breast core needle specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002; 117:797-799
26. Middleton LP, Shakeitha G, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol 2003; 16:120-129
27. Bauer VP, Ditkoff MA, Schnabel F, Brenin D, El-Tamer M, Smith S. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 2003; 9:4-9
28. Yeh I, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy: correlation with excision specimen. Arch Pathol Lab Med 2003; 127:49-54
29. Dmytrasz K, Tartter PI, Mizrachy H, Chinitz L, Smith SR, Estabrook A. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 2003; 9:10-12
30. Crisi MG, Mandavilli S, Cronin E, Ricci A. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol 2003; 27:325-333
31. Dershaw DD. Does LCIS or ALH without other high-risk lesions diagnosed on core biopsy require surgical excision? Breast J 2003; 9:1-3
32. Foster MC, Helvie MA, Gregory NE, Rebner M, Nees AV, Paramagul C. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary? Radiology 2004; 231:813-819
33. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ. Am J Surg Path 2005; 29:534-543
34. Bassett L, Winchester DP, Caplan RB, et al. Stereotactic core-needle biopsy of the breast: a report of the Joint Task Force of the American College of Radiology, American College of Surgeons, and College of American Pathologists. CA: A Cancer Journal for Clinicians 1997; 47:171-190
35. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR 2001; 176:1255-1259
36. Simpson PT, Gale T, Fulford LG, Reis-Filho JS, Lakhani SR. Pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003; 5:258-262